Doctor profile · Federal record
Dr. Holly Glover, PA-C
Physician Assistant · Medical Physician Assistant · Dallas, TX
- NPI 1508104589
- Accepts Medicare
- MIPS 82.0 / 100 · 2023
- 14 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1935 Medical District Dr
Dallas, TX 752357701
(214) 456-8000
fax (214) 456-8006
Credentials & registration
- NPI registered
- January 2013 — 13 yrs on file
- Profile last updated
- November 20, 2013
- Year of graduation
- 2012 — 14 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State license (1)
- Texas #PA08301
- Medicaid (2)
- TX #319842601 · TX #319842602
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1508104589. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,627
Distinct HCPCS
10
Medicare allowed
$67,842
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 726 | 127 | $5 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 258 | 218 | $74 | |
17000 |
Destruction of precancer skin growth, 1 growth | 189 | 162 | $43 | |
17110 |
Destruction of skin growth, 1-14 growths | 142 | 124 | $92 | |
11102 |
Biopsy of related skin growth, first growth | 84 | 82 | $75 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 78 | 73 | $46 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 59 | 59 | $92 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 34 | 29 | $138 | |
11103 |
Biopsy of related skin growth, each additional growth | 26 | 19 | $41 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 17 | 15 | $105 |
In context: peer comparison
Among 190 peers in this city , average services per provider: 90. This provider delivers 18× the peer median.Open Payments
Industry payments received
All-time total
$108,773
Transactions
273
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Dermavant Sciences, Inc. | 63 | $44,221.74 | |
| E.R. Squibb & Sons, L.L.C. | 76 | $32,925.07 | |
| Lilly USA, LLC | 39 | $16,682.97 | |
| LEO Pharma Inc. | 12 | $8,267.77 | |
| Regeneron Healthcare Solutions, Inc. | 15 | $4,391.22 | |
| GENZYME CORPORATION | 9 | $454.42 | |
| ABBVIE INC. | 16 | $295.37 | |
| Novartis Pharmaceuticals Corporation | 6 | $289.07 | |
| Janssen Biotech, Inc. | 11 | $259.90 | |
| PFIZER INC. | 6 | $258.70 | |
| Amgen Inc. | 5 | $235.13 | |
| Incyte Corporation | 5 | $169.22 | |
| Arcutis Biotherapeutics, Inc. | 4 | $113.64 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $99.83 | |
| UCB, Inc. | 3 | $52.29 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
562
Patients
355
Total drug cost
$108,639
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 163 | 128 | $2,251 |
| Clobetasol Propionate | Generic | 100 | 59 | $7,602 |
| Mupirocin | Generic | 76 | 48 | $716 |
| Doxycycline Hyclate | Generic | 44 | 30 | $1,144 |
| Ketoconazole | Generic | 36 | 29 | $960 |
| Fluorouracil | Generic | 34 | 31 | $3,545 |
| Nystatin | Generic | 29 | 17 | $494 |
| Econazole Nitrate | Generic | 15 | 0 | $789 |
| Cephalexin | Generic | 14 | 13 | $361 |
| Minoxidil | Generic | 13 | 0 | $160 |
Frequently asked questions
What is Dr. Holly Glover's medical specialty?
Dr. Holly Glover practices Physician Assistant in Dallas, TX.
Where does Dr. Holly Glover practice?
Dr. Holly Glover practices at 1935 Medical District Dr, Dallas, TX 752357701. Office phone: 2144568000.
What is Dr. Holly Glover's NPI?
Dr. Holly Glover's National Provider Identifier (NPI) is 1508104589, issued by NPPES.
Does Dr. Holly Glover accept Medicare assignment?
Yes. Dr. Holly Glover accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Holly Glover commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.